“…However, in men, androgen ablation therapy for prostate cancer leads to few or no significant deficits in cognitive performance (Nelson et al, 2008; Alibhai et al, 2010a; Alibhai et al, 2010b; Matousek and Sherwin, 2010). The reduced levels of androgens in aging men are often considered to be a contributing factor to diseases that increase with age such as Alzheimer’s disease (Fuller et al, 2007; Drummond et al, 2009; Barron and Pike, 2011; Luchetti et al, 2011), epilepsy (Herzog, 1991; Harden and MacLusky, 2004; 2005; Frye, 2006; Reddy, 2010; Stevens and Harden, 2011) and Parkinson’s disease (Al Sweidi et al, 2011). However, direct evidence in support of this idea, such as prevention of these diseases by androgen therapy, is generally weak, although androgens ameliorate symptoms in some instancess (Herzog, 1991; Almeida and Flicker, 2003; Cherrier et al, 2005; Harden and MacLusky, 2005; Driscoll and Resnick, 2007).…”